Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Testicular Neoplasms × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Ifosfamide 8 Carboplatin 7 Paclitaxel 5 Filgrastim 5 Etoposide 5 Dexamethasone 3 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Ondansetron 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Calcium Dobesilate 2 Aprepitant 2 tremelimumab 1 thymoglobulin 1 poly ICLC 1 pembrolizumab 1 palifosfamide lysine 1 palbociclib 1 isophosphamide mustard 1 fosaprepitant 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 dehydroftorafur 1 cytokine inducible SH2-containing protein 1 alvocidib 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡